Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio (2023 - 2024)

Oramed Pharmaceuticals' Interest Coverage Ratio history spans 2 years, with the latest figure at 12.01 for Q2 2024.

  • For Q2 2024, Interest Coverage Ratio changed N/A year-over-year to 12.01; the TTM value through Jun 2025 reached 50.62, down 3785.26%, while the annual FY2024 figure was 3.92, 847.49% down from the prior year.
  • Interest Coverage Ratio reached 12.01 in Q2 2024 per ORMP's latest filing, down from 5.0 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 10.7 in Q4 2023 to a low of 12.01 in Q2 2024.